Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 4 Study of Curosurf (Poractant) and Survanta (Beractant) Surfactant Treatment in Very Premature Infants With Respiratory Distress Syndrome.

NCT00767039 is registered in ClinicalTrials.gov with Alan Fujii as lead sponsor.

NCT NCT00767039
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00767039 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 4 Study of Curosurf (Poractant) and Survanta (Beractant) Surfactant Treatment in Very Premature Infants With Respiratory Distress Syndrome.
Lead sponsor
Alan Fujii
Phase
Phase 4
Overall status
Terminated
Start date
January 31, 2005
Completion date
January 31, 2009
Enrollment
52 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

patent ductus arteriosus, prematurity, respiratory distress syndrome